Rapamycin Targets STAT3 and Impacts C-Myc to Suppress Tumor Growth

Researchers used a chemical proteomics strategy that had identified STAT3, a transcription factor considered to be undruggable, as a direct functional protein target of rapamycin. They showed that rapamycin treatment in cell culture significantly inhibited c-Myc-regulated gene expression.